Retargeting adenovirus gene therapy via the epidermal growth factor receptor

Retargeting adenovirus gene therapy via the epidermal growth factor receptor

Bibliographic Details
Main Authors:	Morrison, J, Briggs, S, Hale, A, Green, N, Herbert, C, Fisher, K, Kehoe, S, Seymour, L
Format:	Journal article
Published:	2006

Similar Items

Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
by: Morrison, J, et al.
Published: (2009)

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
by: Morrison, J, et al.
Published: (2008)

Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
by: Green, N, et al.
Published: (2008)

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
by: Fisher, K, et al.
Published: (2001)

HPMA copolymers for masking and retargeting of therapeutic viruses.
by: Fisher, K, et al.
Published: (2010)

Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
by: Fisher, K, et al.
Published: (2007)

Glycoviruses: chemical glycosylation retargets adenoviral gene transfer.
by: Pearce, O, et al.
Published: (2005)

E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells.
by: Bachtarzi, H, et al.
Published: (2011)

The effect of polymer coating and different adenovirus serotypes on the innate immune responses to intraperitoneal adenovirus
by: Thoma, C, et al.
Published: (2008)

Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA.
by: Carlisle, R, et al.
Published: (2006)

Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma.
by: Martin J Hicks, et al.
Published: (2016-01-01)

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
by: Carlisle, R, et al.
Published: (2009)

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.
by: Carlisle, R, et al.
Published: (2009)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
by: Hill, C, et al.
Published: (2021)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
by: Claudia Hill, et al.
Published: (2021-06-01)

Lactoferrin Retargets Human Adenoviruses to TLR4 to Induce an Abortive NLRP3-Associated Pyroptotic Response in Human Phagocytes
by: Coraline Chéneau, et al.
Published: (2021-05-01)

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins.
by: Bachtarzi, H, et al.
Published: (2011)

Modular Chimeric Antigen Receptor Systems for Universal CAR T Cell Retargeting
by: Ashley R. Sutherland, et al.
Published: (2020-09-01)

Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
by: Maki Watanabe, et al.
Published: (2021-12-01)

Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein
by: Elisabeth A van Erp, et al.
Published: (2015-01-01)

Adenovirus type 5 (Ad5) is sequestered and inactivated by binding to coxsackievirus and adenovirus receptor (CAR) and complement receptor 1 (CR1) on human erythrocytes
by: Carlisle, R, et al.
Published: (2008)

Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera.
by: Carlisle, R, et al.
Published: (2008)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
by: Green, N, et al.
Published: (2012)

Automatic facial motion tracking and retargeting
by: Do Le, Bao Nguyen
Published: (2009)

Image and video retargeting by seam carving
by: Ong, Wee Jin.
Published: (2009)

Endothelial Retargeting of AAV9 In Vivo
by: Tarik Bozoglu, et al.
Published: (2022-03-01)

Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types
by: Nagarjun Kasaraneni, et al.
Published: (2017-12-01)

Adenovirus: teaching an old dog new tricks.
by: Seymour, L, et al.
Published: (2011)

Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin
by: Dash, P, et al.
Published: (2000)

Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population.
by: Kitao, K, et al.
Published: (2007)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
by: Takuma Suzuki, et al.
Published: (2021-09-01)

Epidermal growth factor receptor blockers for the treatment of ovarian cancer
by: Morrison, J, et al.
Published: (2018)

Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
by: Lobke C.M. Hensen, et al.
Published: (2020-09-01)

A retargetable C compiler : design and implementation /
by: 371499 Fraser, Christopher W., et al.
Published: (1995)

Unresponsive customers : acquisition, retargeting and win-back
by: Ringvald, Alan O, et al.
Published: (2016)

Tools for retargeting proteins within Aspergillus nidulans.
by: Subbulakshmi Suresh, et al.
Published: (2017-01-01)

Depth Trajectory-Aware Stereoscopic Video Retargeting
by: Xuejin Wang, et al.
Published: (2021-01-01)

Retargeting the management of hypercholesterolemia – focus on evolocumab
by: Colletti A, et al.
Published: (2016-09-01)

Retargeting of pre-set regions on chromosome for high gene expression in mammalian cells
by: Jiao, Peng, et al.
Published: (2004)

Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor–tyrosine kinase inhibitors
by: Huang-Chih Chang, et al.
Published: (2017-03-01)